A real-world analysis of safety profile of selexipag by using FDA adverse Event Reporting System (FAERS).

Zhao, Jie; Wang, Mei; Yu, Qing; Yang, Yi; Zhang, Bin; Zhan, Sanhua

Zhao, Jie; Wang, Mei; Yu, Qing; Yang, Yi; Zhang, Bin; Zhan, Sanhua.

Afiliação

Zhao J; Department of Pharmacy, Tongling People's Hospital, Tongling, Anhui Province, China.
Wang M; Department of Pharmacy, Tongling Sixth People's Hospital, Tongling, Anhui Province, China.
Yu Q; Department of Pharmacy, Tongling People's Hospital, Tongling, Anhui Province, China.
Yang Y; Department of Infection, The First Affiliated Hospital Of Anhui Medical University, Hefei, Anhui Province, China.
Zhang B; Department of Cardiovascular, Tongling People's Hospital, Tongling, Anhui Province, China.
Zhan S; Department of Pharmacy, Tongling People's Hospital, Tongling, Anhui Province, China.

Expert Opin Drug Saf ; : 1-12, 2023 Nov 30.

Article em En | MEDLINE | ID: mdl-38032065

Palavras-chave

FAERS; Selexipag; adverse events; case reports; safety profile

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Expert Opin Drug Saf Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google